Systemic reactions from allergen immu... [J Allergy Clin Immunol. 1992] - PubMed

loading

Review Position paper on allergen immunotherapy. Report of a BSACI working party. January-October 1992. [Clin Exp Allergy. 1993]
Review Position paper on allergen immunotherapy. Report of a BSACI working party. January-October 1992.
. Clin Exp Allergy. 1993 Aug; 23 Suppl 3:1-44.
Allergen immunotherapy. [Mayo Clin Proc. 2007]
Allergen immunotherapy.
Rank MA, Li JT. Mayo Clin Proc. 2007 Sep; 82(9):1119-23.
The local and systemic side-effects of venom and inhaled-allergen subcutaneous immunotherapy. [Wien Klin Wochenschr. 2009]
The local and systemic side-effects of venom and inhaled-allergen subcutaneous immunotherapy.
Adamic K, Zidarn M, Bajrovic N, Erzen R, Kopac P, Music E. Wien Klin Wochenschr. 2009; 121(9-10):357-60.
Review [Preventive immunotherapy]. [Allergol Immunopathol (Madr). ...]
Review [Preventive immunotherapy].
Boquete M, Carballada F, Expósito F, González A. Allergol Immunopathol (Madr). 2000 May-Jun; 28(3):89-93.
Review 25. Immunotherapy of allergic disease. [J Allergy Clin Immunol. 2003]
Review 25. Immunotherapy of allergic disease.
Frew AJ. J Allergy Clin Immunol. 2003 Feb; 111(2 Suppl):S712-9.

Navigating the updated anaphylaxis parameters. [Allergy Asthma Clin Immunol. 2...]
Navigating the updated anaphylaxis parameters.
Kemp SF. Allergy Asthma Clin Immunol. 2007 Jun 15; 3(2):40-9. Epub 2007 Jun 15.
How safe are the biologicals in treating asthma and rhinitis? [Allergy Asthma Clin Immunol. 2...]
How safe are the biologicals in treating asthma and rhinitis?
Cox LS. Allergy Asthma Clin Immunol. 2009 Oct 22; 5(1):4. Epub 2009 Oct 22.
Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trial. [Proc Natl Acad Sci U S A. 2008]
Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trial.
Senti G, Prinz Vavricka BM, Erdmann I, Diaz MI, Markus R, McCormack SJ, Simard JJ, Wüthrich B, Crameri R, Graf N, et al. Proc Natl Acad Sci U S A. 2008 Nov 18; 105(46):17908-12. Epub 2008 Nov 10.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Systemic reactions from allergen immunotherapy.
Systemic reactions from allergen immunotherapy.
J Allergy Clin Immunol. 1992 Oct ;90(4 Pt 1):567-78.

PubMed
An update on bronchopulmonary dysplasia: is there a relationship to the developm...
An update on bronchopulmonary dysplasia: is there a relationship to the development of childhood asthma?
Med Hypotheses. 2003 Oct ;61(4):495-502.

PubMed
Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies.
Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies.
Br J Pharmacol. 1991 Mar ;102(3):769-73.

PubMed
Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine...
Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies.
Clin Exp Allergy. 2003 Sep ;33(9):1198-208.

PubMed
Neuropeptide Y is a vasoconstrictor in human nasal mucosa.
Neuropeptide Y is a vasoconstrictor in human nasal mucosa.
J Appl Physiol. 1992 Nov ;73(5):1867-72.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed